BLFS

BioLife Solutions Inc.

Price

$36.47

return (12m)

48.61%

p/e

29.61

p/bv

4.09

DIVIDEND YIELD

0.00%

BLFS price

BioLife Solutions

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment BLFS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

25.95%

3 months

47.41%

1 year

48.61%

2 years

38.04%

5 years

-22.01%

10 years

1,860.75%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals BLFS

Valuation

P/E

29.61

Sector -2.19

Industry 1.21

P/BV

4.09

Sector 2.22

Industry 2.11

P/Revenue (PSR)

16.70

Sector 2.01

Industry 0.78

EV/EBITDA

651.21

Sector -17.81

Industry -25.30

EV/EBIT

961.49

Sector -26.72

Industry -18.04

P/EBITDA

267.44

Sector 0.36

Industry 0.18

P/EBIT

574.23

Sector -3.34

Industry 1.26

P/Total Assets

3.84

Sector 1.23

Industry 0.86

P/Net Current Assets

15.94

Sector -27.35

Industry -12.37

P/Working Capital

14.16

Sector -4.54

Industry -49.48

EPS

1.18

Sector -0.87

Industry -0.55

BVPS

8.57

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

63.88%

Sector 43.36%

Industry 31.53%

EBITDA Margin

8.82%

Sector -323.65%

Industry -73.39%

EBIT Margin

5.97%

Sector -194.57%

Industry -11.94%

Operating Margin

2.91%

Sector -24.37%

Industry -9.87%

Net Profit Margins

56.38%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.06

Sector 0.12

Industry 0.22

Profitability

ROE

13.80%

Sector -33.82%

Industry -37.56%

ROA

12.96%

Sector -29.63%

Industry -17.56%

ROIC

2.03%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

9.69

Sector 1.84

Industry 1.14

Net Debt / EBITDA

-32.84

Sector -1.47

Industry -31.86

Net Debt / EBIT

-48.48

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.20

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.51

Equity/Assets

0.94

Sector 0.42

Industry 0.25

Liabilities/Assets

0.06

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

-2.90%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

FAIR VALUE OF BioLife Solutions ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$36.47

Fair Value

$15.08

Upside Return potential.

-58.64%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals BLFS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
BLFS BioLife Solutions Inc.	$36.47	48.86%	0.00%	29.61	4.09	13.80%	56.38%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%
DXCM DexCom Inc.	$89.88	11.21%	0.00%	34.58	13.19	38.14%	20.12%
EW Edwards Lifesciences Corp.	$92.28	17.85%	0.00%	52.70	4.94	9.37%	15.43%
BDX Becton Dickinson and Company	$187.60	-0.85%	2.30%	53.25	2.05	3.85%	4.05%
IMRA Imara Inc.	$0.00	-100.00%	92.02%	65.05	1.13	1.74%	0.00%
BDXB Becton Dickinson and Company	$0.00	-100.00%	0.00%	8.75	0.54	6.12%	8.36%
ALGN Align Technology Inc.	$163.04	13.40%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.40	26.40%	1.45%	48.10	10.90	22.66%	26.71%
SNN Smith & Nephew PLC	$29.30	-16.53%	2.61%	11.16	2.43	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

BLFS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BioLife Solutions

BioLife Solutions Inc.

Average Investor10 user rating

4.0 (1 people)

United States

39 years

Founded: 1987

1992

Time since IPO - 34 years

199

Employees

BioLife Solutions Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.72 billion, with shareholders equity totaling $420.00 million.

The company employs approximately 199 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, BioLife Solutions Inc. reported $102.83 million in revenue, generating net income of $57.98 million.

Key financial metrics include a P/E ratio of 29.61, a price-to-book (P/B) ratio of 4.09, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BLFS.

Market cap

$1.72 billion

Net worth

$420.00 million

$420,000,000.00

Assets

$447.49 million

$447,490,000.00

Total Shares Outstanding

49.00 million

49,000,000

Average Daily Trading Volume

$1.17 million

$1,167,441.24

Sector

Health

Industry

Medical Supplies and Equipment

BLFS

BLFS revenue and profits

Financial Results BLFS

DRAG THE FRAME TO SEE MORE DATA

BLFS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87